Litcius/Paper detail

Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells

Bin Gu, Bingyu Shi, Xiang Zhang, Shi-Yuan Zhou, Jianhong Chu, Xiaojin Wu, Chengcheng Fu, Huiying Qiu, Yue Han, Suning Chen, Lei Yu, Xiao Ma, Depei Wu

2020Bone Marrow Transplantation30 citationsDOI

Topics & Concepts

MedicineHaematopoiesisStem cellTransplantationAcute lymphocytic leukemiaChimeric antigen receptorCD19Philadelphia chromosomeImmunologyRefractory (planetary science)LeukemiaHematopoietic stem cell transplantationAcute leukemiaLymphoblastic LeukemiaInternal medicineAntigenOncologyCancer researchT cellChromosomal translocationBiologyImmune systemGeneticsAstrobiologyGeneCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia Treatments
Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells | Litcius